NCT01835015View on ClinicalTrials.gov

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Age-related Macular Degeneration
Interventions
DRUG

CLG561

Administered by intravitreal injection, Day 1

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01835015 - Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter